Ambu A/S Class B AMBU_B

Ambu AS (AMBFF) delivers 16% organic growth in endoscopy solutions and improved EBIT margin, while navigating FX and tariff challenges.

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Neonatal Intensive Care Respiratory Devices Market size & share revenue was valued at approximately USD 2.1 Billion in 2025 and is expected to reach USD 2.3 Billion in 2026 and is expected to reach around USD 5.7 Billion by 2035, at a CAGR of 10.5% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Inspirat

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Gastrointestinal Endoscopy Devices Market size & share revenue was valued at approximately USD 11.6 Billion in 2025 and is expected to reach USD 12.2 Billion in 2026 and is expected to reach around USD 19.6 Billion by 2035, at a CAGR of 5.4% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are HOYA Corporatio

In May 2026, European markets have shown resilience with the pan-European STOXX Europe 600 Index rising by 3.00%, driven by optimism surrounding potential de-escalation in the Middle East. Despite a reduction in growth forecasts due to energy shocks and geopolitical challenges, investor interest remains strong for growth companies where high insider ownership can signal confidence and alignment with shareholder interests.

As European markets grapple with rising energy costs and geopolitical tensions, the STOXX Europe 600 Index recently saw a decline of 0.85%, reflecting broader concerns about inflationary pressures and interest rate hikes. Despite these challenges, robust corporate earnings growth highlights potential opportunities for investors seeking undervalued stocks in the region. In this environment, identifying stocks trading below their fair value can be crucial for investors aiming to capitalize on...

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Flexible Endoscope Market size & share revenue was valued at approximately USD 12.7 Billion in 2025 and is expected to reach USD 13.5 Billion in 2026 and is expected to reach around USD 22.7 Billion by 2035, at a CAGR of 6% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Olympus Corporation, Cook Medical

As European markets face challenges with geopolitical risks and economic uncertainties, traditionally defensive sectors have shown resilience while major indices like Germany's DAX and France’s CAC 40 have experienced declines. In this environment, growth companies with high insider ownership can offer a unique appeal to investors, as they often indicate strong management confidence and alignment of interests, which may be particularly valuable amidst the current market volatility.

As European markets navigate the complexities of Middle East tensions and energy market volatility, investor sentiment has shown resilience, with the STOXX Europe 600 Index rising by nearly 4% in early April. Amid these fluctuations, identifying undervalued stocks becomes crucial for investors seeking opportunities that align with current economic conditions and potential growth prospects.

Amidst heightened uncertainty and inflation risks, the European market has been navigating a challenging landscape, with the STOXX Europe 600 Index recently experiencing a decline of 3.79% due to geopolitical tensions and soaring energy prices. In such an environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong internal confidence and alignment with shareholder interests.

As European markets face a pullback amid concerns about overvaluation in artificial intelligence-related stocks, investors are increasingly cautious, with major indexes such as Germany's DAX and France's CAC 40 experiencing notable declines. In this climate of uncertainty, companies with strong insider ownership often attract attention as they may indicate confidence from those closest to the business.

The Europe integrated LED light source endoscope market is set to surge to $1.10 billion by 2035, rising from $241.6 million in 2024, at a CAGR of 14.02%. This growth is driven by advancements in LED technology, improved patient outcomes from minimally invasive procedures, and Europe's aging population. Key benefits of LED sources include longer lifespan, enhanced image quality, and energy efficiency over conventional options. Regulatory support and an increase in chronic illnesses propel market

Technological advancements, such as AI integration, enhance diagnostics and patient compliance, are propelling market expansion. Despite challenges like high screening costs and limited reimbursement policies, increasing awareness of early detection supports market growth. Colon Screening Market Colon Screening Market Dublin, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The "Colon Screening Market Size and Growth Trends and Forecast Report 2025-2033" has been added to ResearchAndMarkets.com's offering.The

Novo Holdings plans to elect Lars Green, former CFO of Novozymes (now Novonesis), as Chair of its Board of Directors and Britt Meelby Jensen, CEO of Ambu, as Vice Chair. Lars Rebien Sørensen will step down as Chair.